Event Reports

On 7 October, the Leaders of the Pharmaceutical & Medical Technology Working Group convened a meeting to discuss plans for the Working Group’s upcoming events, as well as brainstorm ideas and concepts for future events. The Group held a lively discussion on upcoming events that highlight healthcare reforms and the importance of healthcare communications in the digital era. The meeting was chaired by the Head of the Working Group and Country Head of Public Affairs, Communications & Engagement at Novartis Indonesia, Hanum Yahya and was attended by Dr. Harimurti Listianto (the Head of Government Affairs at APL Care), Wulaning Putri (Head of Government Affairs & Business Development at Siemens Healthineers), and Arinda Wahyuningtyas (Communications & Engagement at Novartis Indonesia), along with the EuroCham secretariat.

On the 6th of October, EuroCham attended the National Drug and Food Control Agency (BPOM) socialization on the Implementation of Monitoring the Side Effects of Traditional Medicines, Quasi Drugs, and Health Supplements. The socialization was led by Irwan (Director of Supervision of Traditional Medicines and Health Supplements of BPOM) and Drh. Rachmi Setyorini (Director of Standardization of Traditional Medicines, Health Supplements, and Cosmetics).

The first session highlights the lack of regulation in monitoring the side-effects of quasi-drugs stems from the circulation and distribution of quasi-drugs. Therefore, the BPOM ensures that they will provide a strong legal umbrella based on the Regulation No. 4 of 2021 over the side-effects of quasi-drugs. The second session emphasized the constraints for business players in regards to Regulation No. 17 of 2019 regarding the Quality Requirement for Health Supplements.